LIVN
- LivaNova PLC
()
Overview
Company Summary
LivaNova PLC is a global medical technology company that specializes in developing and manufacturing innovative medical devices for the treatment of cardiovascular and neurological diseases. The company focuses on offering advanced therapies and solutions in the fields of cardiac surgery, neuromodulation, and cardiovascular diagnostics.
In the field of cardiac surgery, LivaNova provides a range of innovative products and technologies used in open heart surgery, such as heart-lung machines, oxygenators, autotransfusion systems, and surgical ablation devices. These products are designed to support surgeons in performing safe and effective cardiac procedures.
Additionally, LivaNova is involved in the development of neuromodulation solutions to treat neurological conditions. This includes the production of implanted devices, such as vagus nerve stimulation (VNS) therapy systems, which are used to control seizures in patients with drug-resistant epilepsy. The company also focuses on developing innovative solutions to address other neurological disorders.
LivaNova further offers cardiovascular diagnostic solutions, including advanced monitoring technologies, software, and data management tools. These solutions enable healthcare professionals to monitor patients' cardiac performance effectively, aiding in the diagnosis and treatment of cardiovascular diseases.
The company's ultimate goal is to improve patient outcomes and enhance the quality of life for individuals living with heart and brain-related conditions. By developing innovative medical devices and solutions, LivaNova PLC aims to provide healthcare professionals with the tools they need to deliver effective and personalized care.